Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia

• Published in: Annals of hematology Vol. 101; no. 7; pp. 1459 - 1464
• Main Authors: Kaynar, Lale Aydın, Gökçen, Sanem, Can, Ferda, Yeğin, Zeynep Arzu, Özkurt, Zübeyde Nur, Yağcı, Münci
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-07-2022; Springer Nature B.V
• Subjects: Anemia; Hematology; Hemoglobin; Iron; Medicine; Medicine & Public Health; Oncology; Original Article; Iron-deficiency anemia; Hepcidin; Every other day treatment
• ISSN: 0939-5555; 1432-0584
• DOI: 10.1007/s00277-022-04835-6

Iron-deficiency anemia (IDA) is accepted as the most common cause of anemia in the world. The main goals of iron replacement therapy are to normalize the hemoglobin level and to replace iron stores. Current guidelines for treating iron deficiency recommend daily divided doses of iron to increase absorption. Hepcidin is a key regulator of systemic iron balance and acts in harmony with intracellular iron metabolism. Daily dosing and divided doses may increase serum hepcidin and decrease iron absorption. In this study, it was aimed to compare the effectiveness of daily and every other day oral iron replacement therapy in women of reproductive age with iron-deficiency anemia. We included premenopausal female patients aged between 18 and 50 years with iron-deficiency anemia. Forty patients were given oral iron therapy at a daily dose of 2*80 mg (iron sulfate). Forty-three patients were given iron treatment at a dose of 2*80 mg (iron sulfate) every other day. After 2 months of oral iron therapy, there was a significant improvement in hemoglobin, mean corpuscular volume, serum iron, total iron-binding capacity, and transferrin saturation in both groups. The values of hemoglobin, serum iron, transferrin saturation, and ferritin significantly increased at the end of the treatment for both groups. Although the median hepcidin level on the 15th-day measurement in the every other day treatment group was higher than that in the daily treatment group, there was no significant difference. As a result, the patients’ compliance with the treatment can be increased by offering treatment every other day instead of daily, since it provides similar treatment effectiveness.